Amphastar Pharmaceuticals, Inc.·4

Mar 6, 9:02 PM ET

PETERS WILLIAM J 4

4 · Amphastar Pharmaceuticals, Inc. · Filed Mar 6, 2026

Research Summary

AI-generated summary of this filing

Updated

Amphastar CFO William J. Peters Sells 1,744 Shares

What Happened

  • William J. Peters, Amphastar Pharmaceuticals' CFO, EVP & Treasurer and a director, had 1,744 shares withheld to satisfy tax withholding on vested restricted stock units (RSUs). The shares were recorded as disposed at $19.96 per share, for a total value of $34,810.

Key Details

  • Transaction date: March 4, 2026
  • Price: $19.96 per share
  • Total shares withheld/disposed: 1,744 — total value $34,810
  • Shares owned after transaction: not specified in the filing
  • Footnotes: F1 — shares were withheld to satisfy tax liability on RSU vesting; F2 — filing notes inclusion of 545 shares acquired May 31, 2025 under the company ESPP
  • Transaction code: F (tax withholding); filing submitted March 6, 2026 (no late-filing flag shown)

Context

  • This was a tax-withholding disposition tied to RSU vesting (a common, administrative action), not an open-market sale intended to take profits. Such withholding is routine and does not necessarily signal the insider's view of the company's prospects.

Insider Transaction Report

Form 4
Period: 2026-03-04
PETERS WILLIAM J
DirectorCFO, EVP & TREASURER
Transactions
  • Tax Payment

    Common Stock

    [F1][F2]
    2026-03-04$19.96/sh1,744$34,810123,786 total
Footnotes (2)
  • [F1]The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.
  • [F2]Includes 545 shares acquired on May 31, 2025 under the Issuer's 2014 Employee Stock Purchase Plan.
Signature
/s/ William J. Peters|2026-03-06

Documents

1 file
  • 4
    form4-03072026_020346.xmlPrimary